For equity-compensated executives
You want to diversify. You're also an insider. Enter the 10b5-1 plan.
For an insider, the obstacle to diversification is rarely conviction. It is the calendar. Trading windows open for a few weeks, close on the rumor of anything material, and have a way of being shut precisely when you finally decided to act. A Rule 10b5-1 plan solves the calendar problem by replacing decisions with a schedule: a written plan, adopted when you hold no material nonpublic information, that sells on autopilot regardless of what you later learn. The variable that makes or breaks these plans is the discipline at adoption, because everything after that is meant to be mechanical.
What actually makes a plan valid?
The plan must be adopted in good faith, during an open window, while you are not aware of material nonpublic information, and it must fix the amounts, prices, and dates of sales, or hand the formula to someone else entirely. Since the SEC's amendments took effect in 2023, insiders must also certify those conditions in the plan itself, and companies now disclose the adoption and termination of officer and director plans in their quarterly filings. Your sales are visible. That is a feature: a pre-announced, formulaic schedule reads as planning, while opportunistic window trades read as something else.
How long until it starts selling?
For directors and Section 16 officers, no trade can occur until the later of ninety days after adoption or two business days after the company files the 10-Q or 10-K covering the quarter in which the plan was adopted, capped at 120 days. For employees below that line, the cooling-off period is thirty days. The detail that surprises people: modifying the price, amount, or timing terms counts as adopting a new plan and restarts the clock. Overlapping plans are heavily restricted, and single-trade plans are limited to one in any twelve-month period. The regime is built to reward one thoughtful plan over many clever ones.
What should the schedule actually look like?
It should be the output of your financial plan, not a guess. If the target is bringing a forty percent position down to fifteen over two years, the plan sells the difference on a regular cadence, sized so that any single sale date matters little. Pure time-based schedules are the most robust. Price limits can be layered in, but every limit is a bet that can strand shares unsold below it for years, which quietly defeats the purpose the plan was built for.
Where these plans go wrong
Terminating a plan early is legal but corrosive: it invites the question of what you knew, and a pattern of adopting and canceling can undermine the good-faith foundation of every plan you touch. The other failure is treating the plan as a market call rather than a diversification tool, loading it with limit prices that express a view. If you knew the stock's path, you would not need the plan. The plan exists because you do not.
The principle to carry
A 10b5-1 plan converts a recurring, compromised decision into a single clean one. Make that one decision carefully, in an open window, sized to the plan behind it, and then let it run.
Aspirean designs 10b5-1 programs alongside the executive's broader plan, so the selling schedule serves the diversification target rather than existing for its own sake. If your window keeps closing before you act, that is the moment to talk.
This piece is general education, not individual advice. Whether any of it applies to you depends on your specifics, which is exactly the conversation to have before acting.
Meet with us
Bring us the question behind this one.
Every piece here started as a question a client asked. If you’re carrying one of your own, we’d love the opportunity to talk with you.
Begin a conversation